- Previous Close
0.0787 - Open
0.0788 - Bid 0.0651 x --
- Ask 0.0880 x --
- Day's Range
0.0788 - 0.0900 - 52 Week Range
0.0080 - 0.1800 - Volume
15,000 - Avg. Volume
224,054 - Market Cap (intraday)
539,181 - Beta (5Y Monthly) 2.37
- PE Ratio (TTM)
-- - EPS (TTM)
-0.1300 - Earnings Date --
- Forward Dividend & Yield --
- Ex-Dividend Date --
- 1y Target Est
--
Aibotics Inc. focuses on psychedelics for the treatment of mental health issues. It provides psychedelic therapies for the treatment of post-traumatic stress disorder, palliative care, depression, and anxiety. The company was formerly known as Mycotopia Therapies, Inc. and changed its name to Aibotics Inc. in February 2025 Aibotics Inc. is based in Miami, Florida. Aibotics Inc. is a subsidiary of EHAVE, Inc.
www.mycotopiatherapies.comRecent News: AIBT
View MorePerformance Overview: AIBT
Trailing total returns as of 2/24/2025, which may include dividends or other distributions. Benchmark is .
YTD Return
1-Year Return
3-Year Return
5-Year Return
Compare To: AIBT
Select to analyze similar companies using key performance metrics; select up to 4 stocks.
Statistics: AIBT
View MoreValuation Measures
Market Cap
471.48k
Enterprise Value
1.53M
Trailing P/E
--
Forward P/E
--
PEG Ratio (5yr expected)
--
Price/Sales (ttm)
--
Price/Book (mrq)
--
Enterprise Value/Revenue
--
Enterprise Value/EBITDA
--
Financial Highlights
Profitability and Income Statement
Profit Margin
0.00%
Return on Assets (ttm)
-84.57%
Return on Equity (ttm)
--
Revenue (ttm)
--
Net Income Avi to Common (ttm)
-1.65M
Diluted EPS (ttm)
-0.1300
Balance Sheet and Cash Flow
Total Cash (mrq)
202.36k
Total Debt/Equity (mrq)
--
Levered Free Cash Flow (ttm)
2.31M